Literature DB >> 27738963

Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Minhee Kim1,2, Luca Borradori3, Dédée F Murrell4,5.   

Abstract

Elderly patients are more susceptible to the development of autoimmune blistering disorders such as bullous pemphigoid, mucous membrane pemphigoid, epidermolysis bullosa acquisita, and paraneoplastic pemphigus. This article focuses on the clinical aspects of the aforementioned autoimmune blistering diseases and highlights the important factors involved in treating elderly patients. It is essential for clinicians to offer individualized treatment plans for these patients to optimize outcomes, as elderly patients often have multiple co-morbidities, polypharmacy, and suboptimal socioeconomic status that can adversely influence adequate compliance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27738963     DOI: 10.1007/s40266-016-0402-1

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  98 in total

1.  Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept.

Authors:  Christopher Sacher; Andrea Rubbert; Cathrin König; Karin Scharffetter-Kochanek; Thomas Krieg; Nicolas Hunzelmann
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

2.  Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.

Authors:  Y J Chen; C Y Wu; M W Lin; T J Chen; K K Liao; Y C Chen; C Y Hwang; S Y Chu; C C Chen; D D Lee; Y T Chang; W J Wang; H N Liu
Journal:  Br J Dermatol       Date:  2011-07-28       Impact factor: 9.302

Review 3.  Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management.

Authors:  Maria Kirzhner; Frederick A Jakobiec
Journal:  Semin Ophthalmol       Date:  2011 Jul-Sep       Impact factor: 1.975

4.  Prognostic factors of paraneoplastic pemphigus.

Authors:  Sandy Leger; Damien Picard; Saskia Ingen-Housz-Oro; Jean-Philippe Arnault; François Aubin; Francis Carsuzaa; Gilles Chaumentin; Jacqueline Chevrant-Breton; Olivier Chosidow; Béatrice Crickx; Michel D'incan; Michel Dandurand; Stéphane Debarbieux; Emmanuel Delaporte; Olivier Dereure; Marie-Sylvie Doutre; Gérard Guillet; Denis Jullien; Ingrid Kupfer; Jean-Philippe Lacour; Fabienne Leonard; Catherine Lok; Laurent Machet; Ludovic Martin; Carle Paul; Jean-Michel Pignon; Caroline Robert; Luc Thomas; Pierre-Jean Weiller; Vincent Ferranti; Danièle Gilbert; Philippe Courville; Estelle Houivet; Jacques Benichou; Pascal Joly
Journal:  Arch Dermatol       Date:  2012-10

5.  Treatment of epidermolysis bullosa acquisita with cyclosporine.

Authors:  S M Connolly; H M Sander
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527

Review 6.  [Value of colchicine in treating acquired epidermolysis bullosa].

Authors:  P Berbis; Y Privat
Journal:  Ann Dermatol Venereol       Date:  1989       Impact factor: 0.777

7.  Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania.

Authors:  Adrian Baican; Corina Baican; Gabriela Chiriac; Mircea T Chiriac; Victorina Macovei; Detlef Zillikens; Dorina Ciuce; Cassian Sitaru
Journal:  Int J Dermatol       Date:  2010-07       Impact factor: 2.736

Review 8.  Clinical and immunopathological spectrum of paraneoplastic pemphigus.

Authors:  Jutta Zimmermann; Friedrich Bahmer; Christian Rose; Detlef Zillikens; Enno Schmidt
Journal:  J Dtsch Dermatol Ges       Date:  2010-02-18       Impact factor: 5.584

9.  A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.

Authors:  Erik Letko; Elisabetta Miserocchi; Yassine J Daoud; William Christen; C Stephen Foster; A Razzaque Ahmed
Journal:  Clin Immunol       Date:  2004-06       Impact factor: 3.969

10.  Omalizumab therapy for bullous pemphigoid.

Authors:  Kenneth K Yu; Ashley B Crew; Kelly A N Messingham; Janet A Fairley; David T Woodley
Journal:  J Am Acad Dermatol       Date:  2014-06-20       Impact factor: 15.487

View more
  1 in total

1.  A case of bullous pemphigoid induced by torsemide.

Authors:  Paul Wurtz; Robert Borucki; Corey Georgesen
Journal:  JAAD Case Rep       Date:  2022-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.